Matinas Biopharma Hl (MTNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 0 | 90 | 0 | 0 | 0 |
| Gross Profit | N/A | 90 | N/A | N/A | N/A |
| Operating Expenses | 4,561 | 4,611 | 4,103 | 4,167 | 2,954 |
| Operating Income | -4,561 | -4,521 | -4,103 | -4,167 | -2,954 |
| Other Income | 157 | 1,176 | 52 | 33 | 19 |
| Pre-tax Income | -4,404 | -3,345 | -4,051 | -4,133 | -2,936 |
| Net Income Continuous | -4,404 | -3,345 | -4,051 | -3,627 | -2,936 |
| Net Income | $-4,404 | $-3,345 | $-4,051 | $-3,627 | $-2,936 |
| EPS Basic Total Ops | -1.50 | -1.50 | -2.00 | -1.50 | -1.50 |
| EPS Basic Continuous Ops | -1.40 | -1.17 | -1.73 | -1.62 | -1.55 |
| EPS Diluted Total Ops | -1.50 | -1.50 | -2.00 | -1.50 | -1.50 |
| EPS Diluted Continuous Ops | -1.40 | -1.17 | -1.73 | -1.62 | -1.55 |
| EBITDA(a) | $-4,370 | $-4,323 | $-3,909 | $-4,105 | $-2,898 |